<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Hassing Bengtsson | Activity</title>
	<link>https://www.catswannabecats.com/members/tankhelen53/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/tankhelen53/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hassing Bengtsson.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">593a0609d8b75715ca36a128db83b358</guid>
				<title>Hassing Bengtsson posted an update: Ovarian cancer (OC) and endometrial cancer (EC) are two [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23918/</link>
				<pubDate>Sun, 08 Jun 2025 10:54:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>Ovarian cancer (OC) and endometrial cancer (EC) are two types of the most frequent gynecological malignancies worldwide. However, the prognosis of OC and EC patients remained gloomy. Therefore, there was still an urgent need to identify new biomarkers for early diagnosis and treatment of OC and EC. TCGA datasets were used to screen the KLHL14&hellip;<span class="activity-read-more" id="activity-read-more-23918"><a href="https://www.catswannabecats.com/activity/p/23918/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5b754762444dc026dd723b2d5eeadc5f</guid>
				<title>Hassing Bengtsson posted an update: Objective To determine the frequency of microalbuminuria [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12202/</link>
				<pubDate>Sun, 01 Jun 2025 08:59:26 -0400</pubDate>

									<content:encoded><![CDATA[<p>Objective To determine the frequency of microalbuminuria (MAU) or Moderate Albumin Excretion (MAE) in treatment naïve type II diabetic patients and to compare the frequency of silent myocardial ischemia in treatment naive Type-II diabetic patients with and without microalbuminuria. Methods It was a cross sectional survey conducted in the&hellip;<span class="activity-read-more" id="activity-read-more-12202"><a href="https://www.catswannabecats.com/activity/p/12202/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ec7e3cda40f204525fe9386667a85ff5</guid>
				<title>Hassing Bengtsson posted an update: Results showed that Numb regulates p53 levels in the nucleus [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/9613/</link>
				<pubDate>Sat, 31 May 2025 22:56:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>Results showed that Numb regulates p53 levels in the nucleus where the protein levels of Numb are positively correlated with p53 levels, regardless if it is re-expressed in the MDA-MB-231 cells or knocked down in the MCF-10A cells. Moreover, HDM2 was remarkably decreased only in the membrane fraction of NUMB knock-down cells; however, its mRNA&hellip;<span class="activity-read-more" id="activity-read-more-9613"><a href="https://www.catswannabecats.com/activity/p/9613/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">35904594c10b32b3eb4739940261b8a9</guid>
				<title>Hassing Bengtsson became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/9475/</link>
				<pubDate>Sat, 31 May 2025 22:44:14 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>